Ascendis Pharma (NASDAQ:ASND) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Ascendis Pharma (ASND) operate in?

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Ascendis Pharma Stock (NASDAQ: ASND) stock price, news, charts, stock research, profile.

Open	$137.00
Close	$136.38
Volume / Avg.	690.27K / 484.75K
Day Range	$135.61 - $141.37
52 Wk Range	111.09 - 161.00
Market Cap	$8.16B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	8.87%
Days to Cover	7.66

Recent News

Can BioMarin Stock Live Up to Wall Street's High Expectations?

BioMarin Pharmaceutical (NASDAQ:BMRN) has been a rough investment for a long time. Over the past 10 years, shares have provided a total return of -28%. However, Wall Street analysts have consistently given this stock

MarketBeat

Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?

Novo Nordisk is expected to report third-quarter earnings on Wednesday. Stock up 8.55% in a year, 7.45% year-to-date.

Surbhi Jain

Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

Ascendis Pharma and Novo Nordisk sign exclusive global license for TransCon technology, aiming to advance obesity, type 2 diabetes, and cardiovascular treatments.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$137.00
Close	$136.38
Volume / Avg.	690.27K / 484.75K
Day Range	$135.61 - $141.37
52 Wk Range	111.09 - 161.00
Market Cap	$8.16B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	8.87%
Days to Cover	7.66

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ascendis Pharma (ASND) stock?

You can purchase shares of Ascendis Pharma (NASDAQ:ASND) through any online brokerage.

View our list of the best stock brokerages

Who are Ascendis Pharma (ASND) competitors?

Other companies in Ascendis Pharma’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Ascendis Pharma (ASND) stock?

Ascendis Pharma has a consensus price target of $179.17.

What is the current price for Ascendis Pharma (ASND)?

The stock price for Ascendis Pharma (NASDAQ: ASND) is $136.38 last updated December 20, 2024 at 4:00 PM EST.

Does Ascendis Pharma (ASND) pay a dividend?

There are no upcoming dividends for Ascendis Pharma.

When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?

Ascendis Pharma’s Q4 earnings are confirmed for Wednesday, February 5, 2025.

Is Ascendis Pharma (ASND) going to split?

There is no upcoming split for Ascendis Pharma.

What sector and industry does Ascendis Pharma (ASND) operate in?

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Ascendis Pharma

Ascendis Pharma (ASND) Forecast